Drug repurposing: Hydroxyurea therapy improves the transfusion-free interval in HbE/beta thalassemia major patients with Xmn1 polymorphism
Debojoyti Ghosh, Amrita Panja, Dipankar Saha, Uma Banerjee, Asok Kumar Datta, Anupam Basu
Genetic Testing and Molecular Biomarkers · Aug 1, 2021Peer-reviewedGenetic & Genomic Medicine